Citryll
Oss, NL · Founded 2015 · 38 employees on LinkedIn · 8 known investors
Find your way into Citryll
148 people in our graph share verified history with the Citryll team — schools, employers, funds. One of them is your warm intro.
Laura Contiunlockedknows Renato Chirivi · together at Università degli Studi di Milano (overlapped)
×5knows the team · via Radboud University
×3knows the team · via Scripps Research Institute, La Jolla, Ca, USA
×3knows the team · via Università degli Studi di Milano
Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones. The company is advancing clinical programs in immune-mediated inflammatory diseases, with a current focus on rheumatoid arthritis and hidradenitis suppurativa.
Founders & leadership
Citryll was founded in 2015 by Renato Chirivi.
RC
Renato ChiriviinCo-founder (former CSO)Renato Chirivi is co-founder and former Chief Scientific Officer of Citryll, a clinical-stage biotech company. He has research experience in molecular immunology, antibody discovery and engineering, and protein citrullination, developed through roles at the Mario Negri Institute for Pharmacological Research, The Scripps Research Institute, Nijmegen Center for Molecular Life Sciences, and ModiQuest BV.
Board
PP
Paul Peter TakChair of the Board
Investors · 8
Funding
SEC filings, press & company announcements$92.5M disclosed across 1 round · 2024
- $92.5MSeries BDec 2024 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Citryll do?
- Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones. The company is advancing clinical programs in immune-mediated inflammatory diseases, with a current focus on rheumatoid arthritis and hidradenitis suppurativa.
- Who founded Citryll?
- Citryll was founded by Renato Chirivi in 2015.
- Who are Citryll's investors?
- Citryll's investors include Pureos Bioventures, BioGeneration Ventures, Forbion, Johnson & Johnson Innovation – JJDC, Seventure Partners, BOM, Curie Capital, Novartis Venture Fund.
- How much funding has Citryll raised?
- Citryll has disclosed $92.5M raised across 1 round.
- Where is Citryll headquartered?
- Citryll is headquartered in Oss, NL.